http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-87437-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca8554076aebe15491b62ca8e39a9d25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
filingDate 2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e820e19891b843969210af1dc7414d3
publicationDate 2009-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-87437-C2
titleOfInvention TREATMENT OF HYPERTENSION IN WOMEN WHO ARE SUBJECT TO HORMONE SUBSTITUTION THERAPY
abstract The invention relates to new cycloalkyl compounds that can be used as inhibitors of potassium channel function (in particular, as inhibitors of the K1 subfamily of voltage-controlled K + channels, namely, as K1.5 channel inhibitors that have been associated with ultrafast activating K + - flow of delayed rectifier), the use of these compounds in the prevention and treatment of arrhythmia and I-associated disorders, as well as pharmaceutical compositions that contain such compounds.
priorityDate 2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491762

Total number of triples: 30.